| Melanie Solomon, | |
|
117 N Common St, Lynn, MA 01902-4223 | |
| (781) 598-2759 | |
| Not Available |
| Full Name | Melanie Solomon |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 117 N Common St, Lynn, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013511591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melanie Solomon, 700 Windwood Dr, Tiverton, RI 02878-2496 Ph: () - | Melanie Solomon, 117 N Common St, Lynn, MA 01902-4223 Ph: (781) 598-2759 |
News Archive
The U.S. Food and Drug Administration announced today that injectable drugs used in total parenteral nutrition in critical shortage will be imported into the United States and available to patients this week.
Clinical Data, Inc. today announced that the Company has closed the sale of its genetic and pharmacogenomic testing and biomarker development business to Transgenomic, Inc. for $15.5 million. The sale completes Clinical Data's transformation into a pharmaceutical company with a deep product pipeline, including two promising late-stage compounds, the most advanced of which is vilazodone, a new treatment in development for Major Depressive Disorder.
Omeros Corporation today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic pharmacokinetics when administered alone and concomitantly with approved antipsychotic agents in patients with schizophrenia. OMS824 selectively inhibits PDE10, an enzyme expressed in areas of the brain linked to a wide range of diseases that affect cognition, including schizophrenia and Huntington's disease.
Diabetes Mellitus (DM), a metabolic disorder that affects nearly 170 million people worldwide, is characterized by chronic hyperglycemia that disrupts carbohydrate fat and protein metabolism resulting from defects in insulin secretion, insulin action or both. DM can cause long-term damage, dysfunction and even failure of various organs.
› Verified 3 days ago
Ms. Wendy Fay Gillenson, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 95 Pleasant St, Lynn, MA 01901 Phone: 781-581-4400 | |
Ms. Sarah Catherine Eilers, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 269 Union St, Lynn, MA 01901 Phone: 781-477-7222 | |
Grace Bonaiuto, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 90 Ocallaghan Way, Lynn, MA 01905 Phone: 781-598-0287 | |
Mrs. Maylene Victoria Collado-wulff, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 20 Central Ave, Lynn, MA 01901 Phone: 781-586-6691 | |
Keisha Larosa, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16 City Hall Sq, Frc, Lynn, MA 01901 Phone: 339-883-2401 | |
Taylor Alyson Kurmis, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 101 Green St, Lynn, MA 01902 Phone: 781-593-9434 Fax: 781-691-7034 |